Both TMZ and AP-2α synergistically inhibited the growth and induced the apoptosis of glioma cells, accompanied by decreased levels of Bcl-2, Pro Caspase-3 and the stem cell markers Nanog and Sox2 in a dose-dependent manner (Figure 4F). The gene discussed is BCL2; the disease is central nervous system cancer.